红霉素与阿奇霉素联合治疗小儿支原体肺炎的临床分析

Clinical Analysis of Erythromycin Combined with Azithromycin in the treatment of mycoplasma Pneumonia in Children

目的:分析红霉素与阿奇霉素联合治疗小儿支原体肺炎的疗效。方法:纳入2015年11月~2016年11月某院儿科小儿支原体肺炎共计78例,按数字法随机分为对照组与研究组。对照组38例,采用阿奇霉素治疗;研究组40例,采用红霉素与阿奇霉素联合治疗。治疗后比较两组的疗效。结果:研究组止咳时间、退热时间和住院日更短,治疗总有效率更高,副反应更少,经统计学处理,P<0.05,差异显著,有统计学意义。结论:小儿支原体肺炎采用红霉素与阿奇霉素联合治疗,疗效较显著,病情明显改善,用药副反应少,治疗有效、安全,值得推广。

Objective： To analyze the efficacy of erythromycin combined with azithromycin in the treatment of mycoplasma pneumonia in children. Methods： 78 children with myeoplasma pneumonia treated in a hospital from November 2015 to November 2016 were selected and randomly divided into control group （38 cases,azithromycin treatment） and study group （40 cases, erythromycin combined with azithromycin treat- ment） .After treatment, the efficacy of the two groups was compared.Results：The time of cough, the time of antipyretic and the clays of hospitalization were shorter in the study group, and the treatment effective rate was higher,with less side effects. There was significant difference between the two groups, with statistical significance （P〈0.05）.Conclusion： The effect of erythromyein combined with azithromyein in the treatment of mycoplasma pneumonia in children is obvious,the condition of the disease is obviously improved, the side reaction of drug use is less,and the treatment is effective and safe,which is worthy of promotion application.